(Q36320560)

13 August 2017

1 reference

title

Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management (English)

1 reference

13 August 2017

0 references

0 references

2

Darren K McGuire

1 reference

13 August 2017

John L Petersen

1

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Diabetes and Vascular Disease Research

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

9-15

1 reference

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Follow-up report on the diagnosis of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

PubMed Central: creating an Aladdin's cave of ideas

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Age as independent determinant of glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Is there a glycemic threshold for mortality risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Impaired fasting glucose: how low should it go?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Decreased Insulin Secretion and Increased Insulin Resistance Are Independently Related to the 7-Year Risk of NIDDM in Mexican-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Inflammation in the Prediabetic State Is Related to Increased Insulin Resistance Rather Than Decreased Insulin Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Hypertension and overweight associated with hyperinsulinaemia and glucose tolerance: a longitudinal study of the Finnish and Dutch cohorts of the Seven Countries Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Insulin levels and the natural history of glucose intolerance in Nauruans

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Impaired glucose tolerance and fasting hyperglycaemia have different characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Cardiovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Elevated fasting insulin predicts incident hypertension: the ARIC study. Atherosclerosis Risk in Communities Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Insulin sensitivity and the risk of incident hypertension: insights from the Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Recent advances in our understanding of insulin action and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Ramipril and the development of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Strategies in ongoing clinical trials to reduce cardiovascular disease in patients with diabetes mellitus and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.007

21 January 2018

Identifiers

DOI

10.3132/DVDR.2005.007

1 reference

13 August 2017

1 reference